IL115688A - Process for the preparation of 2-n.butyl-4-spirocyclopentane-1-[[2'-(tetrazol-5-yl) biphenyl-4-yl] methyl-2-imidazoline-5-one in two crystalline forms and a novel crystalline form of said compound - Google Patents

Process for the preparation of 2-n.butyl-4-spirocyclopentane-1-[[2'-(tetrazol-5-yl) biphenyl-4-yl] methyl-2-imidazoline-5-one in two crystalline forms and a novel crystalline form of said compound

Info

Publication number
IL115688A
IL115688A IL11568895A IL11568895A IL115688A IL 115688 A IL115688 A IL 115688A IL 11568895 A IL11568895 A IL 11568895A IL 11568895 A IL11568895 A IL 11568895A IL 115688 A IL115688 A IL 115688A
Authority
IL
Israel
Prior art keywords
butyl
methyl
water
tetrazol
biphenyl
Prior art date
Application number
IL11568895A
Other languages
English (en)
Other versions
IL115688A0 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL115688A0 publication Critical patent/IL115688A0/xx
Publication of IL115688A publication Critical patent/IL115688A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
IL11568895A 1994-10-19 1995-10-19 Process for the preparation of 2-n.butyl-4-spirocyclopentane-1-[[2'-(tetrazol-5-yl) biphenyl-4-yl] methyl-2-imidazoline-5-one in two crystalline forms and a novel crystalline form of said compound IL115688A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412459A FR2725987B1 (fr) 1994-10-19 1994-10-19 Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive

Publications (2)

Publication Number Publication Date
IL115688A0 IL115688A0 (en) 1996-01-19
IL115688A true IL115688A (en) 1999-09-22

Family

ID=9467986

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11568895A IL115688A (en) 1994-10-19 1995-10-19 Process for the preparation of 2-n.butyl-4-spirocyclopentane-1-[[2'-(tetrazol-5-yl) biphenyl-4-yl] methyl-2-imidazoline-5-one in two crystalline forms and a novel crystalline form of said compound

Country Status (27)

Country Link
US (1) US5629331A (de)
EP (1) EP0708103B1 (de)
JP (1) JP3366786B2 (de)
KR (1) KR100251222B1 (de)
CN (1) CN1061656C (de)
AT (1) ATE198478T1 (de)
AU (1) AU698041B2 (de)
CA (1) CA2160725C (de)
CY (1) CY2277B1 (de)
CZ (2) CZ288629B6 (de)
DE (1) DE69519788T2 (de)
DK (1) DK0708103T3 (de)
ES (1) ES2155115T3 (de)
FI (1) FI114156B (de)
FR (1) FR2725987B1 (de)
GR (1) GR3035503T3 (de)
HK (1) HK1005135A1 (de)
HU (1) HU226461B1 (de)
IL (1) IL115688A (de)
NO (1) NO307516B1 (de)
NZ (1) NZ280293A (de)
PL (1) PL184193B1 (de)
PT (1) PT708103E (de)
RU (1) RU2144536C1 (de)
SI (1) SI0708103T1 (de)
TW (1) TW357147B (de)
ZA (1) ZA958850B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
AU767456B2 (en) 1998-07-06 2003-11-13 Bristol-Myers Squibb Company Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
CA2469656A1 (en) * 2001-12-10 2003-06-19 Dr. Reddy's Laboratories Limited Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
ATE340793T1 (de) * 2002-07-16 2006-10-15 Teva Pharma Neue synthese von irbesartan
CN101165062A (zh) * 2003-01-16 2008-04-23 特瓦制药工业有限公司 伊贝沙坦的新合成方法
EP1590343B1 (de) * 2003-02-05 2008-07-16 Teva Pharmaceutical Industries Limited Synthese von 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4-on
AU2003242984A1 (en) * 2003-04-07 2004-11-01 Hetero Drugs Limited A novel crystalline form of irbesartan
WO2005051943A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Processes for the preparation of highly pure irbesartan
DE602005025755D1 (de) 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
WO2006001026A1 (en) * 2004-06-23 2006-01-05 Hetero Drugs Limited Irbesartan polymorphs
SI21849A (sl) * 2004-07-29 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava hidrokloridnih soli tetrazolskega derivata
TWI346108B (en) 2004-08-23 2011-08-01 Bristol Myers Squibb Co A method for preparing irbesartan and intermediates thereof
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
EP1812422B1 (de) 2004-11-11 2013-12-25 LEK Pharmaceuticals d.d. Polymorphe irbesartanform
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
EP1951714A1 (de) 2005-07-27 2008-08-06 Jubilant Organosys Limited Verfahren zur herstellung von 2-(n-butyl)-3-[[2'-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-on
PT1806130E (pt) 2006-01-09 2010-05-11 Krka D D Novo Mesto Composições farmacêuticas sólidas que compreendem irbesartan
WO2008041957A1 (en) * 2006-10-03 2008-04-10 Ulkar Kimya Sanayi Ve Ticaret As Method for producing pure crystalline form of 2-n-butyl-3-((2-(1h-tetrazole-5-yl) (1,1'-biphenyl)-4-methyl)-1,3-diazapspiro (4,4') non -1- en-4-one
EP1918288A1 (de) 2006-11-02 2008-05-07 Cadila Pharmaceuticals Limited Neues und verbessertes Verfahren für die Zubereitung von Irbesartan, einem Angiotensin-II Rezeptorantagonisten für die Behandlung von Bluthochdruck
EP2065035B1 (de) 2007-11-28 2010-07-21 Laboratorios Lesvi, S.L. Pharmazeutische Formulierungen mit Irbesartan
EP2215083A2 (de) * 2007-12-07 2010-08-11 Hetero Drugs Limited Verfahren für reines irbesartan
KR101009383B1 (ko) * 2008-04-30 2011-01-19 켐젠주식회사 고순도의2-부틸-3-[[2'-(1에이취-테트라졸-5-일)[1,1'-비페닐]-4-일]메틸]-1,3-디아자스피로[4.4]논-1-엔-4-온 화합물의제조방법
US8609859B2 (en) * 2009-04-08 2013-12-17 Ctx Life Sciences Pvt. Ltd. One pot process for preparing 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
AR078107A1 (es) * 2009-08-31 2011-10-12 Sanofi Aventis Uso de irbesartan para la preparacion de un medicamento para la prevencion de la hospitalizacion por insuficiencia cardiaca
US8080670B2 (en) 2010-05-04 2011-12-20 Divi's Laboratories, Ltd. Process for the preparation of irbesartan
FR2977253B1 (fr) 2011-06-30 2013-08-09 Centre Nat Rech Scient Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers
IL311793A (en) 2021-10-01 2024-05-01 Sanofi Sa A process for the preparation of active SARTAN compounds having a tetrazole ring

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2697919B2 (ja) * 1989-09-29 1998-01-19 キヤノン株式会社 信号内挿回路及び該回路を備えた変位測定装置
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
IL99372A0 (en) * 1990-09-10 1992-08-18 Ciba Geigy Ag Azacyclic compounds

Also Published As

Publication number Publication date
HK1005135A1 (en) 1998-12-24
IL115688A0 (en) 1996-01-19
FI954992A0 (fi) 1995-10-19
NO954154D0 (no) 1995-10-18
AU698041B2 (en) 1998-10-22
NZ280293A (en) 1997-10-24
CN1061656C (zh) 2001-02-07
CN1128261A (zh) 1996-08-07
CZ288629B6 (cs) 2001-08-15
PL311012A1 (en) 1996-04-29
US5629331A (en) 1997-05-13
CZ271095A3 (en) 1996-05-15
AU3433595A (en) 1996-05-02
PL184193B1 (pl) 2002-09-30
EP0708103B1 (de) 2001-01-03
NO954154L (no) 1996-04-22
KR960014122A (ko) 1996-05-22
ZA958850B (en) 1996-05-27
FI954992A (fi) 1996-04-20
GR3035503T3 (en) 2001-06-29
PT708103E (pt) 2001-06-29
EP0708103A1 (de) 1996-04-24
SI0708103T1 (en) 2001-04-30
NO307516B1 (no) 2000-04-17
KR100251222B1 (ko) 2000-05-01
FR2725987A1 (fr) 1996-04-26
DE69519788D1 (de) 2001-02-08
DK0708103T3 (da) 2001-04-23
JP3366786B2 (ja) 2003-01-14
HU9503016D0 (en) 1995-12-28
JPH08208642A (ja) 1996-08-13
HU226461B1 (en) 2008-12-29
ES2155115T3 (es) 2001-05-01
RU2144536C1 (ru) 2000-01-20
DE69519788T2 (de) 2001-08-30
FI114156B (fi) 2004-08-31
HUT73179A (en) 1996-06-28
CA2160725A1 (en) 1996-04-20
CA2160725C (en) 2001-12-18
CY2277B1 (en) 2003-07-04
CZ288624B6 (cs) 2001-08-15
FR2725987B1 (fr) 1997-01-10
TW357147B (en) 1999-05-01
ATE198478T1 (de) 2001-01-15

Similar Documents

Publication Publication Date Title
IL115688A (en) Process for the preparation of 2-n.butyl-4-spirocyclopentane-1-[[2'-(tetrazol-5-yl) biphenyl-4-yl] methyl-2-imidazoline-5-one in two crystalline forms and a novel crystalline form of said compound
RU95118109A (ru) Способ получения производного тетразола, способ получения формы b производного тетразола, форма b производного тетразола и фармацевтическая композиция на основе производного тетразола формы b
CA2229000A1 (en) 1-biphenylimidazole derivatives, their preparation and their therapeutic use
EP1630182A3 (de) Polymer zur Verwendung in der Verminderung von Aluminosilicatablagerungen in einem Bayer-Verfahren
ATE235471T1 (de) Neue benzylpyrimidine
WO2002012202A3 (en) Processes for the preparation of benzotriazole uv absorbers
CA2698384A1 (en) 3-pyridyl enantiomers and their use as analgesics
NO307932B1 (no) Tetrazolylfenylborsyremellomprodukter for syntese av AII- reseptorantagonister
CA2243544A1 (en) 7-amino-2-heptenoates and their use in the preparation of methylphenidate
EP1568697A4 (de) 1,3-benzothiazinonderivate, deren herstellungsverfahren und verwendung
AU764260B2 (en) Method of producing cyclene
KR840003250A (ko) 3-(1h-테트라졸-5-일)-4-(3h)-퀴나졸리논의 제조방법
大江真道 et al. Changes in the characteristic of dry matter production of japonica type paddy rice (Oryza sativa L.) due to the deep-water treatment
CA2081135A1 (en) Method for precipitating an organic resin from an alkaline solution thereof
TH43759A3 (th) สีย้อมโมโนอาโซที่ไม่ละลายน้ำ

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired